Shiga Progression of Diabetes, Nephropathy and Retinopathy

NAUnknownINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Pioglitazone add on to SU or biguanide

As an initial dosing, 15mg/day of pioglitazone is administered to the patients for 2 years, who are taking SU or biguanide.

DRUG

SU or Biguanide

As an initial dose,a common dose of SU or biguanide is administered to the patients for 2 years.

Trial Locations (1)

520-2192

RECRUITING

Shiga University of Medical Science, Ōtsu

Sponsors
All Listed Sponsors
collaborator

Kanazawa Medical University

OTHER

collaborator

Nagahama Red Cross Hospital

OTHER

collaborator

Nagahama City Hospital

OTHER

collaborator

Kohka Public Hospital

UNKNOWN

collaborator

Second Okamoto General Hospital

UNKNOWN

collaborator

Omihachiman COmmunity Medical Center

UNKNOWN

collaborator

Yasu Hospital

UNKNOWN

collaborator

Toyosato Hospital

UNKNOWN

collaborator

Ako City Hospital

OTHER

collaborator

Horide Clinic

UNKNOWN

collaborator

Kawabata Clinic

UNKNOWN

collaborator

Seta Clinic

UNKNOWN

collaborator

Shiga Clinic

UNKNOWN

collaborator

Osaka University

OTHER

collaborator

NTT West Osaka Hospital

UNKNOWN

collaborator

Hyogo prefectural Amagasaki Hospital

UNKNOWN

collaborator

Tomita Clinic

UNKNOWN

collaborator

Sawada Clinic

UNKNOWN

collaborator

Social Insurance Shiga Hospital

UNKNOWN

lead

Shiga University

OTHER